DCGO · NASDAQ
DocGo (DCGO) Stock Price & Fundamentals
DocGo (DCGO) closed at $563.48 on Oct 9, 2026, down 0.78% from the previous close of $567.91.
Share price, past year
1Y +17.82%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $563.48 |
| Sep 30, 2026 | $554.65 |
| Aug 31, 2026 | $513.70 |
| Jul 31, 2026 | $512.17 |
| Jun 30, 2026 | $518.04 |
| May 29, 2026 | $495.39 |
| Apr 30, 2026 | $487.72 |
| Mar 31, 2026 | $499.33 |
| Feb 27, 2026 | $530.81 |
| Jan 30, 2026 | $511.03 |
| Dec 31, 2025 | $507.91 |
| Nov 28, 2025 | $488.06 |
| Oct 31, 2025 | $473.89 |
Key statistics
- Market cap
- $55.70B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.95
- Revenue (TTM)
- $294.72M
- Net income (TTM)
- −$192.42M
- Shares outstanding
- 98.9M
- Dividend yield
- —
- 52-week range
- $465.98 – $567.91
DocGo's market cap is $55.70B, based on a share price of $563.48 and 98.9M shares outstanding as of Jun 30, 2026.
Financials
DocGo reported revenue of $322.20M for fiscal 2025, down 47.74% from fiscal 2024.
DocGo reported a net loss of $182.40M in fiscal 2025.
DocGo's fiscal 2025 net loss was its first in at least 5 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $322.20M | −47.7% | −$182.40M | −56.6% | −$1.84 | $29.91M |
| FY2024ended Dec 31, 2024 | $616.56M | −1.2% | $19.99M | 3.2% | $0.18 | $66.50M |
| FY2023ended Dec 31, 2023 | $624.29M | +41.7% | $6.86M | 1.1% | $0.06 | −$71.81M |
| FY2022ended Dec 31, 2022 | $440.52M | +38.2% | $34.58M | 7.9% | $0.34 | $25.67M |
| FY2021ended Dec 31, 2021 | $318.72M | +238.7% | $23.74M | 7.5% | $0.25 | −$6.76M |
| FY2020ended Dec 31, 2020 | $94.09M | — | −$14.80M | −15.7% | −$0.25 | −$15.02M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $73.42M | −$15.82M | −$0.16 |
| Q1 FY2026ended Mar 31, 2026 | $75.55M | −$14.76M | −$0.15 |
| Q4 FY2025ended Dec 31, 2025 | $74.94M | −$134.07M | −$1.36 |
| Q3 FY2025ended Sep 30, 2025 | $70.81M | −$27.77M | −$0.28 |
| Q2 FY2025ended Jun 30, 2025 | $80.42M | −$11.16M | −$0.11 |
| Q1 FY2025ended Mar 31, 2025 | $96.03M | −$9.41M | −$0.09 |
| Q4 FY2024ended Dec 31, 2024 | $120.83M | −$3.26M | −$0.03 |
| Q3 FY2024ended Sep 30, 2024 | $138.68M | $5.50M | $0.05 |
Company profile
- Name
- DocGo Inc.
- Ticker
- DCGO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Health Services
- Headquarters
- 685 Third Avenue, 9th Floor, New York, NY 10017
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001822359
Recent SEC filings
- Oct 5, 2026
- Aug 17, 2026
- Aug 17, 2026
- Jul 31, 2026
- Jul 2, 2026
- Jun 18, 2026
- May 11, 2026
- May 11, 2026
Frequently asked questions
What is DocGo's stock price?
DocGo (DCGO) closed at $563.48 on Oct 9, 2026, down 0.78% from the previous close of $567.91.
What is DocGo's market cap?
DocGo's market cap is $55.70B, based on a share price of $563.48 and 98.9M shares outstanding as of Jun 30, 2026.
How much revenue does DocGo make?
DocGo reported revenue of $322.20M for fiscal 2025, down 47.74% from fiscal 2024.
Does DocGo pay a dividend?
DocGo's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DocGo Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures